Annual Accounts Receivable
$38.00 M
-$1.00 M-2.56%
31 December 2023
Summary:
Arcus Biosciences annual accounts receivable is currently $38.00 million, with the most recent change of -$1.00 million (-2.56%) on 31 December 2023. During the last 3 years, it has risen by +$36.95 million (+3522.50%). RCUS annual accounts receivable is now -94.90% below its all-time high of $745.00 million, reached on 31 December 2021.RCUS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$16.00 M
-$12.00 M-42.86%
30 September 2024
Summary:
Arcus Biosciences quarterly accounts receivable is currently $16.00 million, with the most recent change of -$12.00 million (-42.86%) on 30 September 2024. Over the past year, it has dropped by -$36.00 million (-69.23%). RCUS quarterly accounts receivable is now -97.85% below its all-time high of $745.00 million, reached on 31 December 2021.RCUS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.6% | -69.2% |
| 3 y3 years | +3522.5% | +1737.0% |
| 5 y5 years | +100.0% | +203.3% |
RCUS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -94.9% | +3522.5% | -97.8% | +1737.0% |
| 5 y | 5 years | -94.9% | -97.8% | >+9999.0% | |
| alltime | all time | -94.9% | -97.8% |
Arcus Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.00 M(-42.9%) |
| June 2024 | - | $28.00 M(-20.0%) |
| Mar 2024 | - | $35.00 M(-7.9%) |
| Dec 2023 | $38.00 M(-2.6%) | $38.00 M(-26.9%) |
| Sept 2023 | - | $52.00 M(+52.9%) |
| June 2023 | - | $34.00 M(+3.0%) |
| Mar 2023 | - | $33.00 M(-15.4%) |
| Dec 2022 | $39.00 M(-94.8%) | $39.00 M(+42.9%) |
| Sept 2022 | - | $27.29 M(-23.8%) |
| June 2022 | - | $35.83 M(+21.8%) |
| Mar 2022 | - | $29.42 M(-96.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $745.00 M(>+9900.0%) | $745.00 M(>+9900.0%) |
| Sept 2021 | - | $871.00 K(-44.7%) |
| June 2021 | - | $1.57 M(-69.9%) |
| Mar 2021 | - | $5.24 M(+399.0%) |
| Dec 2020 | $1.05 M(+694.7%) | $1.05 M(-59.3%) |
| Sept 2020 | - | $2.58 M(+1061.7%) |
| June 2020 | - | $222.00 K(-35.5%) |
| Mar 2020 | - | $344.00 K(+160.6%) |
| Dec 2019 | $132.00 K(>+9900.0%) | $132.00 K(-97.5%) |
| Sept 2019 | - | $5.28 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(-100.0%) |
| Sept 2018 | - | $5.00 M |
FAQ
- What is Arcus Biosciences annual accounts receivable?
- What is the all time high annual accounts receivable for Arcus Biosciences?
- What is Arcus Biosciences annual accounts receivable year-on-year change?
- What is Arcus Biosciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Arcus Biosciences?
- What is Arcus Biosciences quarterly accounts receivable year-on-year change?
What is Arcus Biosciences annual accounts receivable?
The current annual accounts receivable of RCUS is $38.00 M
What is the all time high annual accounts receivable for Arcus Biosciences?
Arcus Biosciences all-time high annual accounts receivable is $745.00 M
What is Arcus Biosciences annual accounts receivable year-on-year change?
Over the past year, RCUS annual accounts receivable has changed by -$1.00 M (-2.56%)
What is Arcus Biosciences quarterly accounts receivable?
The current quarterly accounts receivable of RCUS is $16.00 M
What is the all time high quarterly accounts receivable for Arcus Biosciences?
Arcus Biosciences all-time high quarterly accounts receivable is $745.00 M
What is Arcus Biosciences quarterly accounts receivable year-on-year change?
Over the past year, RCUS quarterly accounts receivable has changed by -$36.00 M (-69.23%)